CASI Pharmaceuticals Inc Cash Flow-to-Debt Ratio
CASI Pharmaceuticals Inc cash flow-to-debt ratio. CASI Pharmaceuticals Inc (CASI) has a Cash Flow-to-Debt Ratio of -0.03x as of March 2023, meaning its operating cash flow of $-843.00K could theoretically repay 0% of its total liabilities ($26.17 Million) in one year. Check CASI cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of CASI Pharmaceuticals Inc (1994–2024)
Cash flow-to-debt ratio of CASI Pharmaceuticals Inc from 1994 to 2024. Historical debt coverage capacity for CASI Pharmaceuticals Inc across 31 annual periods. Check CASI total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CASI Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (1994–2024)
CASI Pharmaceuticals Inc cash flow-to-debt ratio by year from 1994 to 2024. Year-by-year debt coverage analysis for CASI Pharmaceuticals Inc. For the full cash flow conversion analysis, see CASI Pharmaceuticals Inc cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.56x | $-29.22 Million | $51.82 Million | ▼ -44.3% |
| 2023 | -0.39x | $-19.97 Million | $51.10 Million | ▲ +45.7% |
| 2022 | -0.72x | $-21.09 Million | $29.30 Million | ▲ +18.7% |
| 2021 | -0.88x | $-26.84 Million | $30.34 Million | ▲ +17.4% |
| 2020 | -1.07x | $-25.89 Million | $24.16 Million | ▲ +58.7% |
| 2019 | -2.59x | $-23.24 Million | $8.97 Million | ▲ +64.2% |
| 2018 | -7.24x | $-28.58 Million | $3.95 Million | ▼ -642.0% |
| 2017 | -0.98x | $-6.40 Million | $6.56 Million | ▼ -12.3% |
| 2016 | -0.87x | $-6.02 Million | $6.93 Million | ▼ -87.8% |
| 2015 | -0.46x | $-5.51 Million | $11.91 Million | ▼ -35.9% |
| 2014 | -0.34x | $-4.00 Million | $11.73 Million | ▲ +94.1% |
| 2013 | -5.80x | $-3.28 Million | $565.17K | ▼ -94.6% |
| 2012 | -2.98x | $-2.21 Million | $742.75K | ▲ +50.9% |
| 2011 | -6.07x | $-4.27 Million | $704.09K | ▼ -230.8% |
| 2010 | -1.83x | $-4.96 Million | $2.70 Million | ▼ -115.4% |
| 2009 | -0.85x | $-10.21 Million | $11.99 Million | ▲ +5.4% |
| 2008 | -0.90x | $-20.71 Million | $23.00 Million | ▲ +0.0% |
| 2007 | -0.90x | $-23.52 Million | $26.12 Million | ▲ +62.1% |
| 2006 | -2.38x | $-20.77 Million | $8.74 Million | ▼ -15.4% |
| 2005 | -2.06x | $-14.52 Million | $7.05 Million | ▲ +53.8% |
| 2004 | -4.46x | $-16.41 Million | $3.68 Million | ▲ +3.0% |
| 2003 | -4.59x | $-24.25 Million | $5.28 Million | ▼ -74.6% |
| 2002 | -2.63x | $-45.53 Million | $17.30 Million | ▼ -14.5% |
| 2001 | -2.30x | $-52.87 Million | $23.01 Million | ▲ +35.8% |
| 2000 | -3.58x | $-44.25 Million | $12.35 Million | ▲ +1.9% |
| 1999 | -3.65x | $-35.80 Million | $9.80 Million | ▼ -87.0% |
| 1998 | -1.95x | $-12.50 Million | $6.40 Million | ▼ -68.7% |
| 1997 | -1.16x | $-6.60 Million | $5.70 Million | ▼ -236.8% |
| 1996 | -0.34x | $-2.20 Million | $6.40 Million | ▲ +49.7% |
| 1995 | -0.68x | $-4.44 Million | $6.50 Million | ▲ +90.6% |
| 1994 | -7.25x | $-4.35 Million | $600.00K | — |